학술논문
TRANSLATION OF CLINICAL TRIAL TO REAL WORLD PRACTICE: CAN SACUBITRIL-VALSARTAN BE SAFELY TITRATED TO TARGET DOSE, 97/103MG BI-DAILY, IN CLINICAL PRACTICE AND WHAT BASELINE CHARACTERISTICS PREDICT SUCCESSFUL TITRATION?
Document Type
Abstract
Author
Source
In Journal of the American College of Cardiology 12 March 2019 73(9) Supplement 1:704-704
Subject
Language
ISSN
0735-1097